These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and anticholinergic activity of 4-hydroxycoumarin derivatives containing substituted benzyl-1,2,3-triazole moiety. Bagheri SM; Khoobi M; Nadri H; Moradi A; Emami S; Jalili-Baleh L; Jafarpour F; Homayouni Moghadam F; Foroumadi A; Shafiee A Chem Biol Drug Des; 2015 Nov; 86(5):1215-20. PubMed ID: 26010139 [TBL] [Abstract][Full Text] [Related]
3. Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors. Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Asatouri R; Vafadarnejad F; Moghadam FH; Khanavi M; Sharifzadeh M; Akbarzadeh T Eur J Med Chem; 2017 Jan; 125():1200-1212. PubMed ID: 27863370 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer's disease. Le-Nhat-Thuy G; Nguyen Thi N; Pham-The H; Dang Thi TA; Nguyen Thi H; Nguyen Thi TH; Nguyen Hoang S; Nguyen TV Bioorg Med Chem Lett; 2020 Sep; 30(18):127404. PubMed ID: 32717612 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease. Li RS; Wang XB; Hu XJ; Kong LY Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors. Liu S; Shang R; Shi L; Zhou R; He J; Wan DC Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706 [TBL] [Abstract][Full Text] [Related]
7. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies. Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509 [TBL] [Abstract][Full Text] [Related]
11. Total Synthesis of Pulmonarin B and Design of Brominated Phenylacetic Acid/Tacrine Hybrids: Marine Pharmacophore Inspired Discovery of New ChE and Aβ Aggregation Inhibitors. Cheng ZQ; Song JL; Zhu K; Zhang J; Jiang CS; Zhang H Mar Drugs; 2018 Aug; 16(9):. PubMed ID: 30134630 [TBL] [Abstract][Full Text] [Related]
12. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease. Manral A; Saini V; Meena P; Tiwari M Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors. Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease. Wu W; Liang X; Xie G; Chen L; Liu W; Luo G; Zhang P; Yu L; Zheng X; Ji H; Zhang C; Yi W Molecules; 2018 Oct; 23(10):. PubMed ID: 30301153 [TBL] [Abstract][Full Text] [Related]
15. 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment. Korabecny J; Andrs M; Nepovimova E; Dolezal R; Babkova K; Horova A; Malinak D; Mezeiova E; Gorecki L; Sepsova V; Hrabinova M; Soukup O; Jun D; Kuca K Molecules; 2015 Dec; 20(12):22084-101. PubMed ID: 26690394 [TBL] [Abstract][Full Text] [Related]
16. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds. Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388 [TBL] [Abstract][Full Text] [Related]
17. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease. Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin. Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699 [TBL] [Abstract][Full Text] [Related]
20. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents. Galdeano C; Viayna E; Arroyo P; Bidon-Chanal A; Blas JR; Muñoz-Torrero D; Luque FJ Curr Pharm Des; 2010; 16(25):2818-36. PubMed ID: 20698824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]